Navigation Links
Anti-epilepsy drug risk on cognitive function for unborn children
Date:7/21/2009

LIVERPOOL, UK 21 July 2009: Interim results of a study being conducted by scientists at the University of Liverpool suggest that children aged three years and younger, who are born to women taking the anti-epileptic drug sodium valproate whilst pregnant, are likely to have an IQ of six to nine points lower than average.

The research, in collaboration with Emory University in the US and the Central Manchester University Hospitals NHS Foundation Trust, tested more than 300 three-year-olds in the UK and US, whose mothers took one of four anti-epilepsy drugs (AEDs) whilst pregnant. The preliminary findings suggest that children exposed to the drug sodium valproate had lower IQ results than children exposed to other AEDs, regardless of the mother's IQ. The results also took dosage, duration of pregnancy and mother's consumption of folic acid whilst pregnant, into account.

Professor of Clinical Neuropsychology at the University, Gus Baker, said "Our research looked at how exposure to sodium valproate and other AEDs in the womb affected children's everyday life in particular their IQ, memory and language abilities from one to six years of age."

Around 5,000 women with epilepsy become pregnant every year in the UK and the majority of these, including those on AEDs, will experience uncomplicated pregnancies and births. Previous research conducted by the team has already shown that children exposed to AEDs such as sodium valproate in the womb are more likely to suffer birth defects characterised by heart malformations, dysmorphic features and minor limb deformities.

Professor Baker added: "The answer is not as simple as to take women off AEDs altogether as the effects of suffering a seizure can also pose a risk for both mother and unborn child. It is vital that the research is now used to educate women with epilepsy before they start to plan for a family. Women need to be aware of the risks so that they can make informed choices w
'/>"/>

Contact: Kate Spark
kate.spark@liv.ac.uk
44-151-794-2247
University of Liverpool
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
2. Lack of sleep among new school-goers leads to behavioral, cognitive problems
3. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
4. Cognitive Activities Protect Against Alzheimers -- Social and Physical Activities Not Enough
5. Potential new approach to treat cognitive impairments in schizophrenia
6. Cognitive deficits lead to loss of self among cancer patients
7. Research links diet to cognitive decline and dementia
8. First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
9. New research on aging and cognitive training presented at GSAs Annual Meeting
10. Hypertension Linked to Risk of Mild Cognitive Impairment
11. Rhode Island Hospital to study driving ability of cognitively impaired elders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Ticket Down ... 2015 International Champions Cup (ICC) . While the World ... and is held every four years, the International Champions Cup ... the tournament saw the all-time attendance record for soccer in ... from the Big House at the University of Michigan. This ...
(Date:5/4/2015)... 2015 Los Angeles dental implants ... more comfortable and attractive alternative for patients with dentures. ... those who have lost teeth. Unfortunately, they also require ... slip at the worst possible moment and may make ... can also painfully pinch or rub gums, leaving sores ...
(Date:5/4/2015)... New findings released today from a poll conducted ... people diagnosed with a brain tumor needed more information ... at the time of diagnosis, and had only a ... course of treatment. The release of these findings corresponds ... volunteer network, the ABTA CommYOUnity™, dedicated to serving the ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 ... ribbon cutting ceremony at their brand new, 13,700 square ... year. The new building will not only provide fertility ... but will also offer community and educational events to ... new facility is located next door to their current ...
(Date:5/4/2015)... May 04, 2015 New West Medicare ... to Care, LLC to manage outpatient advanced imaging services ... West Medicare ensure its members are provided the right ... , Working closely with New West Medicare’s physicians and ... safe use of advanced imaging and provide an objective ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... Symptoms of low levels of testosterone include erectile ... and anemia.// Testosterone replacement therapy is designed to ... The therapy may be offered as an injection, ... replacement therapy does not increase a man’s risk ...
... less likely to develop high blood pressure say researchers based ... study researchers analyzed data from two large studies, which included ... questionnaires, which asked about their folate and supplemental folic acid ... the start of the study. It was found that younger ...
... research suggests weight loss may be an early sign ... begins before the onset of // definite dementia symptoms ... loss in the elderly is common and may be ... documented in people who already have dementia. For the ...
... has brought with it a new lease of life for ... the uphill struggle doesn’t stop with finding a matching donor. ... has shown that despite all high tech matching done for ... Transplant surgeon Ignazio Marino, M.D., of Thomas Jefferson University Hospital ...
... the use of estrogen replacement therapy with a lower risk ... is known as a good indicator of exposure to estrogen. ... BMD related to the risk of cognitive problems. All of ... of the study. Researchers then measured their BMD at several ...
... the reason some adolescents experience depression could be abnormal ... between ages 13 to 18, half of who had ... was performed to measure the volume of each teen’s ... hippocampus of patients with depression was, on average, 17 ...
Cached Medicine News:
(Date:5/4/2015)... Calif. , May 4, 2015 Rogne ... for psoriasis, today announced that preclinical and mechanism of ... at the Society of Investigative Dermatology (SID) Annual Meeting ... in Atlanta, Georgia . ... advancing the development of RON2315, a novel, low MW ...
(Date:5/4/2015)... WHIPPANY, N.J. , May 4, 2015 ... agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... clinical development for the prevention of thrombosis. Under the ... in areas of high unmet medical need. As ... evaluate the therapeutic profile of ISIS-FXI Rx in ...
(Date:5/4/2015)... BUFFALO, N.Y. , May 4, 2015 /PRNewswire/ ... Stephanie Englert , PharmD, has completed preliminary analysis ... Disorder and Schizophrenia. Resources from Clinical Support Services, ... Medication Reviews (CMR) with patients currently taking psychiatric ... events. The research found that 93% of patients ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... 2, 2012 New Report Added in ... (General, Local, Adjunctive) The World Anesthesia ... , General Anesthesia Local Anesthesia ...   To Browse Full TOC, Tables & Figures visit: ...
... SAN DIEGO, May 2, 2012 Zogenix, Inc. (NASDAQ: ... developing products for the treatment of central nervous system ... submitted a New Drug Application (NDA) to the U.S. ... extended-release capsules), Zogenix,s lead investigational product candidate for the ...
Cached Medicine Technology:ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report 2ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report 3ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report 4ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report 5ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report 6Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 2Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 4Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 5Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 6
30 cm - 11 3/4, packages 5 pcs....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Length-9 (229 mm) Tapered retractor blades. 1/16 x 1/4 (1.6 mm x 19 mm)....
Length 6 (152 mm). Greenberg Retractor Kit is supplied with two primary bars. Primary bars attach to skull clamp....
Medicine Products: